TCI Wealth Advisors’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

TCI Wealth Advisors’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-194	Closed	-$15K	–	2715
2022 Q2	$15K	Hold	194	–	–	﹤0.01%	789
2022 Q1	$5K	Buy	194 +43	+28%	+$1.45K	﹤0.01%	1643
2021 Q4	$7K	Buy	151 +73	+94%	+$3.26K	﹤0.01%	1485
2021 Q3	$5K	Buy	78 +47	+152%	+$3.35K	﹤0.01%	1687
2021 Q2	$2K	Sell	31 -10	-24%	-$739	﹤0.01%	2151
2021 Q1	$4K	Buy	+41	New	+$4.88K	﹤0.01%	1461

TCI Wealth Advisors's TPTX Position: Q3 2022 in Review

TCI Wealth Advisors sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 194 shares — an estimated $15K sold.

TCI Wealth Advisors first reported a position in TPTX in Q1 2021 and held it in 6 quarters. The position peaked at $15K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

TCI Wealth Advisors reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
TCI Wealth Advisors sold 194 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $15K.
TCI Wealth Advisors first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2021 and held it in 6 quarters.
TCI Wealth Advisors's Turning Point Therapeutics, Inc. Common Stock position peaked at $15K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on TCI Wealth Advisors's 13F filing for Q3 2022, filed 8 Nov 2022.